Qualitative and quantitative assessment of endpoints in clinical trials

被引：0
|
作者：
Fridrik, M. A. [1 ]
机构：
[1] Gen Hosp Linz, Ctr Hematol & Med Oncol, Dept Internal Med 3, Linz, Austria
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2010年 / 3卷 / 01期
关键词：
Clinical trial; RECIST; endpoints;
D O I：
10.1007/s12254-010-0178-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This review discusses the complexities of different endpoints in clinical trials. A definition of these endpoints and their value for specific situations will be evaluated.
引用
收藏
页码：33 / 36
页数：4
相关论文
共 50 条
  • [21] Surrogate endpoints for the assessment of efficacy in venous thromboembolism treatment trials
    Lensing, AWA
    HAEMOSTASIS, 1998, 28 : 127 - 130
  • [22] Systematic review of outcomes and endpoints in preventive migraine clinical trials
    McGinley, James S.
    Houts, Carrie R.
    Nishida, Tracy K.
    Buse, Dawn C.
    Lipton, Richard B.
    Goadsby, Peter J.
    Dodick, David W.
    Wirth, R. J.
    HEADACHE, 2021, 61 (02): : 253 - 262
  • [23] The Ongoing Evolution of Optimal Clinical Endpoints for Heart Failure Trials
    Krum, Henry
    Hopper, Ingrid
    JACC-HEART FAILURE, 2015, 3 (08) : 615 - 617
  • [24] Recommendations for including multiple symptoms as endpoints in cancer clinical trials
    Cleeland, Charles S.
    Sloan, Jeff A.
    Cella, David
    Chen, Connie
    Dueck, Amylou C.
    Janjan, Nora A.
    Liepa, Astra M.
    Mallick, Rajiv
    O'Mara, Ann
    Pearson, Jay D.
    Torigoe, Yasuhiro
    Wang, Xin Shelley
    Williams, Loretta A.
    Woodruff, Jeanie F.
    CANCER, 2013, 119 (02) : 411 - 420
  • [25] Systematic review of outcomes and endpoints in acute migraine clinical trials
    Houts, Carrie R.
    McGinley, James S.
    Nishida, Tracy K.
    Buse, Dawn C.
    Wirth, R. J.
    Dodick, David W.
    Goadsby, Peter J.
    Lipton, Richard B.
    HEADACHE, 2021, 61 (02): : 263 - 275
  • [26] Interpreting clinical trials in lung cancer: Impact of methodology and endpoints
    Gralla, Richard J.
    Griesinger, Frank
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (06) : S51 - S58
  • [27] Tests and confidence intervals for secondary endpoints in sequential clinical trials
    Lai, Tze Leung
    Shih, Mei-Chiung
    Su, Zheng
    BIOMETRIKA, 2009, 96 (04) : 903 - 915
  • [28] Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
    Mcdonald, James
    Sayers, Judith
    Anker, Stefan D.
    Arends, Jann
    Balstad, Trude
    Baracos, Vickie
    Brown, Leo
    Bye, Asta
    Dajani, Olav
    Dolan, Ross
    Fallon, Marie T.
    Fraser, Eilidh
    Griel, Christine
    Grzyb, Aleksandra
    Hjermstad, Marianne
    Jamal-Hanjani, Mariam
    Jakobsen, Gunnhild
    Kaasa, Stein
    Mcmillan, Donald
    Maddocks, Matthew
    Philips, Iain
    Ottestad, Inger O.
    Reid, Kieran F.
    Sousa, Mariana S.
    Simpson, Melanie R.
    Vagnildhaug, Ola Magne
    Skipworth, Richard J. E.
    Solheim, Tora S.
    Laird, Barry J. A.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2023, : 1932 - 1948
  • [29] Monotherapy trials: endpoints
    Mattson, RH
    EPILEPSY RESEARCH, 2001, 45 (1-3) : 109 - 117
  • [30] Power and sample size considerations in clinical trials with competing risk endpoints
    Maki, Ellen
    PHARMACEUTICAL STATISTICS, 2006, 5 (03) : 159 - 171
12345